U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H21ClN2O4
Molecular Weight 424.877
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GEDOCARNIL

SMILES

COCC1=C2C(NC3=C2C(OC4=CC=C(Cl)C=C4)=CC=C3)=CN=C1C(=O)OC(C)C

InChI

InChIKey=SLYDYLLJUXFULK-UHFFFAOYSA-N
InChI=1S/C23H21ClN2O4/c1-13(2)29-23(27)22-16(12-28-3)20-18(11-25-22)26-17-5-4-6-19(21(17)20)30-15-9-7-14(24)8-10-15/h4-11,13,26H,12H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C23H21ClN2O4
Molecular Weight 424.877
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Anxiolytic drug, Gedocarnil [SH 530, ZK 113315], was undergoing phase I clinical trials with Schering AG in Germany as a potential nootropic agent. However it`s development for the treatment of cognition disorders was discontinued.

Originator

Approval Year

Substance Class Chemical
Record UNII
BWP53NPW3F
Record Status Validated (UNII)
Record Version